文献速递中枢神经肿瘤放疗放疗物理与技术

微束放射治疗为脑肿瘤血管中小分子打开数日血管通透性窗口

Microbeam Radiation Therapy Opens a Several Days' Vessel Permeability Window for Small Molecules in Brain Tumor Vessels.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2024-02-18

研究在大鼠9L胶质瘤模型中,用单向(肿瘤剂量406 Gy)或双向交叉(2×203 Gy)同步辐射微束放射治疗,通过每日活体磁共振成像从照射前1天至照射后10天测量3种大小分子(Gd-DOTA 0.56 kDa、钆标记白蛋白约74 kDa、钆标记IgG 160 kDa)的血管通透性。结果显示双向微束放射治疗对最小分子更有效地增加肿瘤血管通透性,并在照射后第1至第7天诱导小分子肿瘤血管通透性显著增加,而正常脑组织血管通透性保持稳定;对74和160 kDa较大分子未改变正常或肿瘤血管通透性。

要点

  • 双向交叉微束放射治疗较单向更有效增加肿瘤血管对0.56 kDa小分子的通透性。
  • 双向微束放射治疗在照射后第1至第7天诱导小分子肿瘤血管通透性显著增加。
  • 正常脑组织血管通透性保持稳定;74和160 kDa分子未获得通透性窗口。

核心结论

  • 高剂量双向交叉微束放射治疗在照射后第1至第7天诱导肿瘤血管对小分子的通透性显著增加,而正常脑组织血管通透性保持稳定。
  • 该通透性窗口可能有助于静脉小分子(≤0.56 kDa)高效安全地递送至肿瘤组织。
  • 大于钆标记白蛋白(74 kDa)的分子未获得通透性窗口,介于这两种大小之间的分子血管通透性尚未确定。

研究设计与样本

  • 研究为在大鼠9L胶质瘤模型中开展的实验研究。
  • 大鼠接受单向微束放射治疗(肿瘤剂量406 Gy)或双向交叉微束放射治疗(2×203 Gy)。
  • 通过每日活体磁共振成像测量3种大小分子(Gd-DOTA 0.56 kDa、钆标记白蛋白约74 kDa、钆标记IgG 160 kDa)的血管通透性,时间从照射前1天至照射后10天。

主要发现

  • 双向微束放射治疗对最小分子(Gd-DOTA 0.56 kDa)增加肿瘤血管通透性的效果优于单向微束放射治疗。
  • 双向微束放射治疗对正常对侧血管通透性的影响程度与单向微束放射治疗不同。
  • 双向微束放射治疗未改变正常或肿瘤血管对两种较大分子(74和160 kDa)的通透性。
  • 双向微束放射治疗在照射后第1至第7天诱导小分子肿瘤血管通透性显著增加,而正常脑组织血管通透性保持稳定。

关键数值与推荐

  • 单向微束放射治疗肿瘤剂量为406 Gy,双向交叉微束放射治疗为2×203 Gy。
  • 小分子为Gd-DOTA(Dotarem,0.56 kDa),较大分子为钆标记白蛋白(约74 kDa)和钆标记IgG(160 kDa)。
  • 通透性窗口时间为照射后第1至第7天,针对小分子(≤0.56 kDa)。
  • 大于钆标记白蛋白(74 kDa)的分子未获得通透性窗口,介于0.56和74 kDa之间的分子通透性尚未确定。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Synchrotron microbeam radiation therapy (MRT), based on an inhomogeneous geometric and microscopic irradiation pattern of the tissues with high-dose and high-dose-rate x-rays, enhances the permeability of brain tumor vessels. This study attempted to determine the time and size range of the permeability window induced by MRT in the blood-brain (tumor) barrier. METHODS AND MATERIALS: Rats-bearing 9L gliomas were exposed to MRT, either unidirectional (tumor dose, 406 Gy) or bidirectional (crossfired) (2 × 203 Gy). We measured vessel permeability to molecules of 3 sizes (Gd-DOTA, Dotarem, 0.56 kDa; gadolinium-labeled albumin, ∼74 kDa; and gadolinium-labeled IgG, 160 kDa) by daily in vivo magnetic resonance imaging, from 1 day before to 10 days after irradiation. RESULTS: An equivalent tumor dose of bidirectional MRT delivered from 2 orthogonal directions increased tumor vessel permeability for the smallest molecule tested more effectively than unidirectional MRT. Bidirectional MRT also affected the permeability of normal contralateral vessels to a different extent than unidirectional MRT. Conversely, bidirectional MRT did not modify the permeability of normal or tumor vessels for both larger molecules (74 and 160 kDa). CONCLUSIONS: High-dose bidirectional (cross-fired) MRT induced a significant increase in tumor vessel permeability for small molecules between the first and the seventh day after irradiation, whereas permeability of vessels in normal brain tissue remained stable. Such a permeability window could facilitate an efficient and safe delivery of intravenous small molecules (≤0.56 kDa) to tumoral tissues. A permeability window was not achieved by molecules larger than gado-grafted albumin (74 kDa). Vascular permeability for molecules between these 2 sizes has not been determined.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Potez M, Rome C, Lemasson B, et al. Microbeam Radiation Therapy Opens a Several Days' Vessel Permeability Window for Small Molecules in Brain Tumor Vessels. Int J Radiat Oncol Biol Phys. 2024. PMID: 38373658. doi:10.1016/j.ijrobp.2024.02.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。